Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Recs

0
Player Avatar trovak79 (< 20) Submitted: 10/2/2008 12:43:54 PM : Outperform Start Price: $13.97 MRX Score: +144.14

Cash/share = price

Featured Broker Partners


Advertisement